I'll listen again. I though she said at the site of injection... I hope for the patients sake and for the investors sake that the regression is at other sites. Even an understanding of the mechanism at the site of the injection would be an advancement in our understanding and a positive outcome.
At about 25 minutes and 40 seconds she describes what they are looking for as "tumor necrosis" where they injected it. I don't doubt that there is more to the story... I'm just trying to listen carefully at what is being said and determine if I'm hearing good news or outstanding news. I think killing at the injection site is good news, they have replicated the previous work by others in published trials. Now, have they advanced from that point? I'll bet they have but she didn't say it (maybe couldn't) and so I will wait like everyone else for news. I would think at some point some one in the trial might let it leak out that tumors other than at the injection site have regressed if that is in fact the case. That would be news you would want to share with others struggling with cancer.
News 
Market Data 
Discover 
AI
